Sphingosine-1-phosphate induced vasoconstriction is increased in the isolated perfused kidneys of diabetic rats

Diabetes Research and Clinical Practice

Volumn 94, Issue 1, 2011, Pages

  Bautista Pérez, Rocio ^a   Arellano, Abraham ^a   Franco, Martha ^a   Osorio, Horacio ^a   Coronel, Israel ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Diabetes; Kidney; S1P 2 receptor; Sphingosine 1 phosphate

Indexed keywords

SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ISOLATED KIDNEY; KIDNEY PERFUSION; MALE; NONHUMAN; PROTEIN EXPRESSION; VASOCONSTRICTION;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS; KIDNEY; LYSOPHOSPHOLIPIDS; MALE; RATS; RATS, WISTAR; RECEPTORS, LYSOSPHINGOLIPID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHINGOSINE; VASOCONSTRICTION;

EID: 80054894571     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.06.023     Document Type: Article

References (20)

1. Kim R.H., Takabe K., Milstien S., Spiegel S. Export and functions of sphingosine-1-phosphate. Biochim Biophys Acta 2009, 1791(7):692-696.
2. Dantas A.P., Igarashi J., Michel T. Sphingosine 1-phosphate and control of vascular tone. Am J Physiol Heart Circ Physiol 2003, 284:H2045-H2052.
3. Tosaka M., Okajima F., Hashiba Y., Saito N., Nagano T., Watanabe T., et al. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 2001, 32:2913-2919.
4. Coussin F., Scott R.H., Wise A., Nixon G.F. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ Res 2002, 91:151-157.
5. Hemmings D.G., Hudson N.K., Halliday D., O'Hara M., Baker P.N., Davidge S.T., et al. Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone. Biol Reprod 2006, 74(1):88-94.
6. Choi S.K., Ahn D.S., Lee Y.H. Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery. Cardiovasc Res 2009, 82(2):324-332.
7. Bischoff A., Czyborra P., Fetscher C., Meyer Zu Heringdorf D., Jakobs K.H., Michel M.C. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol 2000, 130:1871-1877.
8. Bischoff A., Czyborra P., Meyer Zu Heringdorf D., Jakobs K.H., Michel M.C. Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br J Pharmacol 2000, 130:1878-1883.
9. Bischoff A., Meyer Zu Heringdorf D., Jakobs K.H., Michel M.C. Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats. Br J Pharmacol 2000, 132:1925-1933.
10. Geoffroy K., Troncy L., Wiernsperger N., Lagarde M., El Bawab S. Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels. FEBS Lett 2005, 579(5):1249-1254.
11. Osorio H., Bautista R., Rios A., Franco M., Santamaría J., Escalante B. Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats. Diabetes Res Clin Pract 2009, 86(3):e46-e49.
12. Bautista R., Sánchez A., Hernández J., Oyekan A., Escalante B. Angiotensin II type AT2 receptor mRNA expression and renal vasodilatation are increased in renal failure. Hypertension. 2001, 38:669-673.
13. Salomone S., Potts E.M., Tyndall S., Ip P.C., Chun J., Brinkmann V., et al. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol 2008, 153(1):140-147.
14. Liu G., Han F., Yang Y., Xie Y., Jiang H., Mao Y., et al. Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin. Nephrol Dial Transplant 2011, 26(5):1493-1502.
15. Wang L., Xing X.P., Holmes A., Wadham C., Gamble J.R., Vadas M.A., et al. Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ Res 2005, 97(9):891-899.
16. You B., Ren A., Yan G., Sun J. Activation of sphingosine kinase-1 mediates inhibition of vascular smooth muscle cell apoptosis by hyperglycemia. Diabetes 2007, 56(5):1445-1453.
17. Imasawa T., Kitamura H., Ohkawa R., Satoh Y., Miyashita A., Yatomi Y. Unbalanced expression of sphingosine 1-phosphate receptors in diabetic nephropathy. Exp Toxicol Pathol 2010, 62(1):53-60.
18. Imasawa T., Koike K., Ishii I., Chun J., Yatomi Y. Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells. Biochem Biophys Res Commun 2010, 392(2):207-211.
19. Maki T., Gottschalk R., Ogawa N., Monaco A.P. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720. Transplantation 2005, 79(9):1051-1055.
20. Kawanabe T., Kawakami T., Yatomi Y., Shimada S., Soma Y. Sphingosine 1-phosphate accelerates wound healing in diabetic mice. J Dermatol Sci 2007, 48(1):53-60.